|
1
|
He H, Ni J and Huang J: Molecular
mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett.
7:1352–1362. 2014.PubMed/NCBI
|
|
2
|
Chou AJ and Gorlick R: Chemotherapy
resistance in osteosarcoma: Current challenges and future
directions. Expert Rev Anticancer Ther. 6:1075–1085. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Longhi A, Errani C, de Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He JP, Hao Y, Wang XL, Yang XJ, Shao JF,
Guo FJ and Feng JX: Review of the molecular pathogenesis of
osteosarcoma. Asian Pac J Cancer Prev. 15:5967–5976. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Broadhead ML, Clark JC, Myers DE, Dass CR
and Choong PF: The molecular pathogenesis of osteosarcoma: A
review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kobayashi E, Masuda M, Nakayama R,
Ichikawa H, Satow R, Shitashige M, Honda K, Yamaguchi U, Shoji A,
Tochigi N, et al: Reduced argininosuccinate synthetase is a
predictive biomarker for the development of pulmonary metastasis in
patients with osteosarcoma. Mol Cancer Ther. 9:535–544. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hughes DP: Strategies for the targeted
delivery of therapeutics for osteosarcoma. Expert Opin Drug Deliv.
6:1311–1321. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bielack SS, Carrle D, Hardes J, Schuck A
and Paulussen M: Bone tumors in adolescents and young adults. Curr
Treat Options Oncol. 9:67–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Osaki S, Tazawa H, Hasei J, Yamakawa Y,
Omori T, Sugiu K, Komatsubara T, Fujiwara T, Sasaki T, Kunisada T,
et al: Ablation of MCL1 expression by virally induced microRNA-29
reverses chemoresistance in human osteosarcomas. Sci Rep.
6:289532016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lamb J, Crawford ED, Peck D, Modell JW,
Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, et
al: The connectivity map: Using gene-expression signatures to
connect small molecules, genes, and disease. Science.
313:1929–1935. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Li X, Miao Y, Wang Q, Jiang W, Xu C,
Li J, Han J, Zhang F, Gong B and Xu L: SubpathwayMiner: A software
package for flexible identification of pathways. Nucleic Acids Res.
37:e1312009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li C, Shang D, Wang Y, Li J, Han J, Wang
S, Yao Q, Wang Y, Zhang Y, Zhang C, et al: Characterizing the
network of drugs and their affected metabolic subpathways. PLoS
One. 7:e473262012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang D, Yang H, Lin J, Teng Y, Jiang Y,
Chen J and Li Y: 17β-estradiol regulates cell proliferation, colony
formation, migration, invasion and promotes apoptosis by
upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell
MG-63 in an estrogen receptor-independent manner. Biochem Biophys
Res Commun. 457:500–506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moalic S, Liagre B, Corbière C, Bianchi A,
Dauça M, Bordji K and Beneytout JL: A plant steroid, diosgenin,
induces apoptosis, cell cycle arrest and COX activity in
osteosarcoma cells. FEBS Lett. 506:225–230. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moalic S, Liagre B, Le Bail JC and
Beneytout JL: Dose-dependent modulation of apoptosis and
cyclooxygenase-2 expression in human 1547 osteosarcoma cells by
NS-398, a selective cyclooxygenase-2 inhibitor. Int J Oncol.
18:533–540. 2001.PubMed/NCBI
|
|
17
|
Tinti L, Taylor AM, Santucci A, Wlodarski
B, Wilson PJ, Jarvis JC, Fraser WD, Davidson JS, Ranganath LR and
Gallagher JA: Development of an in vitro model to investigate joint
ochronosis in alkaptonuria. Rheumatology. 50:271–277. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Chen JX, Liu JP, You C, Liu YH and
Mao Q: Gain of function of mutant TP53 in glioblastoma: Prognosis
and response to temozolomide. Ann Surg Oncol. 21:1337–1344. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saha P, Debnath C and Bérubé G:
Steroid-linked nitrogen mustards as potential anticancer
therapeutics: A review. J Steroid Biochem Mol Biol. 137:271–300.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bartzatt R: Anticancer agents for
treatment of tumors in the central nervous system by correspondent
substituent substitution and elucidation by pattern recognition
methods. Med Chem. 8:138–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang M, Liao EY, Xu X, Luo XH and Xiao
XH: Effects of progesterone and 18-methyl levonorgestrel on
osteoblastic cells. Endocr Res. 29:483–501. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang S, Wang Y and Li SJ: Lansoprazole
induces apoptosis of breast cancer cells through inhibition of
intracellular proton extrusion. Biochem Biophys Res Commun.
448:424–429. 2014. View Article : Google Scholar : PubMed/NCBI
|
